Federated Hermes
ARQT icon

Federated Hermes’s Arcutis Biotherapeutics ARQT Stock Holding History

Federated Hermes’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.4M Buy
1,077,267
+185,500
+21% +$4.73M 0.04% 413
2025
Q4 		$25.9M Buy
891,767
+132,194
+17% +$3.38M 0.04% 395
2025
Q3 		$14.3M Buy
759,573
+22,204
+3% +$350K 0.03% 484
2025
Q2 		$10.3M Sell
737,369
-186
-0% -$2.61K 0.02% 566
2025
Q1 		$11.5M Buy
737,555
+244,633
+50% +$3.45M 0.02% 527
2024
Q4 		$6.87M Sell
492,922
-8,909
-2% -$97.6K 0.02% 635
2024
Q3 		$4.67M Buy
501,831
+151,717
+43% +$1.5M 0.01% 729
2024
Q2 		$3.26M Hold
350,114
– – 0.01% 812
2024
Q1 		$3.47M Sell
350,114
-171,355
-33% -$1.28M 0.01% 805
2023
Q4 		$1.68M Buy
521,469
+461,469
+769% +$1.25M ﹤0.01% 1000
2023
Q3 		$319K Buy
60,000
+20,000
+50% +$170K ﹤0.01% 1453
2023
Q2 		$381K Buy
40,000
+10,000
+33% +$111K ﹤0.01% 1449
2023
Q1 		$330K Buy
30,000
+6,000
+25% +$86.8K ﹤0.01% 1504
2022
Q4 		$355K Buy
+24,000
New +$419K ﹤0.01% 1442

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return